781
Participants
Start Date
September 30, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
MF/F 200/10 mcg via a metered dose inhaler (MDI) twice daily for 26 weeks
Mometasone furoate MDI (MF MDI) 200 mcg
MF 200 mcg via metered dose inhaler twice daily for 26 weeks
formoterol fumarate 10 mcg
F via metered dose inhaler 10 mcg twice a day for 26 weeks
Placebo
Placebo metered dose inhaler twice a day for 26 weeks
Collaborators (1)
Novartis
INDUSTRY
Organon and Co
INDUSTRY